217 related articles for article (PubMed ID: 28678046)
1. Coagulation Profile Is Not a Predictor of Acute Cerebrovascular Events in Pediatric Extracorporeal Membrane Oxygenation Patients.
Anton-Martin P; Journeycake J; Modem V; Golla S; Raman L; Tweed J; Darnell-Bowens C
ASAIO J; 2017; 63(6):793-801. PubMed ID: 28678046
[TBL] [Abstract][Full Text] [Related]
2. Activated partial thromboplastin time is a better trending tool in pediatric extracorporeal membrane oxygenation.
Maul TM; Wolff EL; Kuch BA; Rosendorff A; Morell VO; Wearden PD
Pediatr Crit Care Med; 2012 Nov; 13(6):e363-71. PubMed ID: 22940857
[TBL] [Abstract][Full Text] [Related]
3. Anticoagulation monitoring during pediatric extracorporeal membrane oxygenation.
Bembea MM; Schwartz JM; Shah N; Colantuoni E; Lehmann CU; Kickler T; Pronovost P; Strouse JJ
ASAIO J; 2013; 59(1):63-8. PubMed ID: 23263338
[TBL] [Abstract][Full Text] [Related]
4. The Impact and Statistical Analysis of a Multifaceted Anticoagulation Strategy in Children Supported on ECMO: Performance and Pitfalls.
Kessel AD; Kline M; Zinger M; McLaughlin D; Silver P; Sweberg TM
J Intensive Care Med; 2017 Jan; 32(1):59-67. PubMed ID: 26319579
[TBL] [Abstract][Full Text] [Related]
5. Pre-ECMO coagulopathy does not increase the occurrence of hemorrhage during extracorporeal support.
Anton-Martin P; Raman L; Thatte N; Tweed J; Modem V; Journeycake J
Int J Artif Organs; 2017 May; 40(5):250-255. PubMed ID: 28430304
[TBL] [Abstract][Full Text] [Related]
6. Anti-factor Xa assay is a superior correlate of heparin dose than activated partial thromboplastin time or activated clotting time in pediatric extracorporeal membrane oxygenation*.
Liveris A; Bello RA; Friedmann P; Duffy MA; Manwani D; Killinger JS; Rodriquez D; Weinstein S
Pediatr Crit Care Med; 2014 Feb; 15(2):e72-9. PubMed ID: 24335992
[TBL] [Abstract][Full Text] [Related]
7. Age-based difference in activation markers of coagulation and fibrinolysis in extracorporeal membrane oxygenation.
Hundalani SG; Nguyen KT; Soundar E; Kostousov V; Bomgaars L; Moise A; Hui SK; Teruya J
Pediatr Crit Care Med; 2014 Jun; 15(5):e198-205. PubMed ID: 24614609
[TBL] [Abstract][Full Text] [Related]
8. Venovenous Extracorporeal Membrane Oxygenation With Prophylactic Subcutaneous Anticoagulation Only: An Observational Study in More Than 60 Patients.
Krueger K; Schmutz A; Zieger B; Kalbhenn J
Artif Organs; 2017 Feb; 41(2):186-192. PubMed ID: 27256966
[TBL] [Abstract][Full Text] [Related]
9. Laboratory and clinical predictors of thrombosis and hemorrhage in 29 pediatric extracorporeal membrane oxygenation nonsurvivors.
Reed RC; Rutledge JC
Pediatr Dev Pathol; 2010; 13(5):385-92. PubMed ID: 20085498
[TBL] [Abstract][Full Text] [Related]
10. Anti-xa directed protocol for anticoagulation management in children supported with extracorporeal membrane oxygenation.
O'Meara LC; Alten JA; Goldberg KG; Timpa JG; Phillips J; Laney D; Borasino S
ASAIO J; 2015; 61(3):339-44. PubMed ID: 25710768
[TBL] [Abstract][Full Text] [Related]
11. Bivalirudin-based versus conventional heparin anticoagulation for postcardiotomy extracorporeal membrane oxygenation.
Ranucci M; Ballotta A; Kandil H; Isgrò G; Carlucci C; Baryshnikova E; Pistuddi V;
Crit Care; 2011; 15(6):R275. PubMed ID: 22099212
[TBL] [Abstract][Full Text] [Related]
12. Coagulations Studies Do Not Correlate With Each Other or With Hematologic Complications During Pediatric Extracorporeal Membrane Oxygenation.
Deshpande SJ; Vitali S; Thiagarajan R; Brediger S; McManus M; Geva A
Pediatr Crit Care Med; 2021 Jun; 22(6):542-552. PubMed ID: 33660700
[TBL] [Abstract][Full Text] [Related]
13. Outcomes following routine antithrombin III replacement during neonatal extracorporeal membrane oxygenation.
Stansfield BK; Wise L; Ham PB; Patel P; Parman M; Jin C; Mathur S; Harshfield G; Bhatia J
J Pediatr Surg; 2017 Apr; 52(4):609-613. PubMed ID: 27847121
[TBL] [Abstract][Full Text] [Related]
14. Correlation Among Antifactor Xa, Activated Partial Thromboplastin Time, and Heparin Dose and Association with Pediatric Extracorporeal Membrane Oxygenation Complications.
McMichael ABV; Hornik CP; Hupp SR; Gordon SE; Ozment CP
ASAIO J; 2020 Mar; 66(3):307-313. PubMed ID: 30883406
[TBL] [Abstract][Full Text] [Related]
15. The use of an extracorporeal membrane oxygenation anticoagulation laboratory protocol is associated with decreased blood product use, decreased hemorrhagic complications, and increased circuit life.
Northrop MS; Sidonio RF; Phillips SE; Smith AH; Daphne HC; Pietsch JB; Bridges BC
Pediatr Crit Care Med; 2015 Jan; 16(1):66-74. PubMed ID: 25319630
[TBL] [Abstract][Full Text] [Related]
16. Primary use of the venovenous approach for extracorporeal membrane oxygenation in pediatric acute respiratory failure.
Pettignano R; Fortenberry JD; Heard ML; Labuz MD; Kesser KC; Tanner AJ; Wagoner SF; Heggen J
Pediatr Crit Care Med; 2003 Jul; 4(3):291-8. PubMed ID: 12831409
[TBL] [Abstract][Full Text] [Related]
17. Comparison of routine laboratory measures of heparin anticoagulation for neonates on extracorporeal membrane oxygenation.
Sulkowski JP; Preston TJ; Cooper JN; Duffy VL; Deans KJ; Chicoine LG; Minneci PC
J Extra Corpor Technol; 2014 Mar; 46(1):69-76. PubMed ID: 24779122
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for intracranial hemorrhage in the extracorporeal membrane oxygenation patient.
Dela Cruz TV; Stewart DL; Winston SJ; Weatherman KS; Phelps JL; Mendoza JC
J Perinatol; 1997; 17(1):18-23. PubMed ID: 9069059
[TBL] [Abstract][Full Text] [Related]
19. Hematological abnormalities in neonatal patients treated with extracorporeal membrane oxygenation (ECMO).
Zavadil DP; Stammers AH; Willett LD; Deptula JJ; Christensen KA; Sydzyik RT
J Extra Corpor Technol; 1998 Jun; 30(2):83-90. PubMed ID: 10182118
[TBL] [Abstract][Full Text] [Related]
20. Antifactor Xa Monitoring and Hematologic Complications of Pediatric Extracorporeal Membrane Oxygenation.
Rama G; Middlesworth W; Neunert C; Streltsova S; Cheung EW
ASAIO J; 2021 Jan; 67(1):91-95. PubMed ID: 33346994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
